title: Safety and efficacy of measles, mumps, and rubella vaccine in patients with DiGeorge syndrome.
authors.forename: Nashat
authors.initials: N
authors.lastname: Al-Sukaiti
authors.forename: Brenda
authors.initials: B
authors.lastname: Reid
authors.forename: Sasson
authors.initials: S
authors.lastname: Lavi
authors.forename: Daifulah
authors.initials: D
authors.lastname: Al-Zaharani
authors.forename: Adelle
authors.initials: A
authors.lastname: Atkinson
authors.forename: Chaim M
authors.initials: CM
authors.lastname: Roifman
authors.forename: Eyal
authors.initials: E
authors.lastname: Grunebaum
mesh_terms: D000293:Adolescent; D000553:Ambulatory Care; D000914:Antibodies, Viral / Q000097:blood; D018791:CD4 Lymphocyte Count; D002648:Child; D002675:Child, Preschool; D004062:DiGeorge Syndrome / Q000276:immunology*; D006801:Humans; D007407:Interviews as Topic; D008457:Measles / Q000517:prevention & control; D008459:Measles virus / Q000276:immunology; D022542:Measles-Mumps-Rubella Vaccine / Q000009:adverse effects* / Q000627:therapeutic use*; D009107:Mumps / Q000517:prevention & control; D009109:Mumps virus / Q000276:immunology; D012409:Rubella / Q000517:prevention & control; D012412:Rubella virus / Q000276:immunology; D013689:Telephone; D014611:Vaccination / Q000009:adverse effects; D055815:Young Adult
chemical_list: D000914:Antibodies, Viral; D022542:Measles-Mumps-Rubella Vaccine